Gels to Repair Hearing Loss? Drugmakers Try New Ear Treatments

October 17, 2016

(Bloomberg) – Drugmakers are jumping in to offer innovative treatments like gels and gene therapy to prevent or even reverse tinnitus and hearing loss — which affect 25 million and 48 million people in the U.S., respectively. Undeterred by recent setbacks in clinical trials, some pharmaceutical companies see hearing-loss drugs turning into a multi-billion dollar market, bolstered by the stigma associated with wearing hearing aids and exposure to loud music through headphones in younger generations.